ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758662 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758662; 2) Community: the network communities that were significantly associated with the response to NSC 758662; 3) Molecule: the relationships between components within communities and NSC 758662; 4) MDR: the compounds that were significantly associated with the NSC 758662.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0247979034812109 -0.076285822
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0247979034812109 -0.00056758323
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0247979034812109 0.087940026
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0247979034812109 -0.033939051
NSC 371777 Null 0.0247979034812109 -0.45772514
NSC 637411 Null 0.0247979034812109 0.0014491738
NSC 638624 Null 0.0247979034812109 -0.19826998
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.0247979034812109 0.19283243
NSC 681632 Camptothecin Derivative 0.0247979034812109 -0.02016119
NSC 681633 Camptothecin Derivative 0.0247979034812109 0.020223356
Total:58  Current:28    [First] [Prev] [Next] [Last]